Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2022.907912
Abstract: Background Cardioembolic stroke (CS) due to atrial fibrillation (AF) bears a high risk of unfavorable outcome. Treatment with a non-vitamin K antagonist oral anticoagulant (NOAC) reduces this risk. NOAC dosage occurs on a thin line…
read more here.
Keywords:
risk incorrect;
noac dosage;
dosage;
risk ... See more keywords